Clyde & Co advised Chronos Therapeutics Limited on the deal. Evgen Pharma plc (AIM:EVG) agreed to acquire Chronos Therapeutics Ltd. for £3.4 million. The total consideration...
You must be a Standard 1 Year member to access this content.
Clyde & Co has advised Chatsworth Schools on the deal. Chatsworth Schools, a rapidly expanding independent schools group backed by leading growth investor Synova, acquired Riverston...
You must be a Standard 1 Year member to access this content.
Clyde & Co has advised Chatsworth Schools on the deal. Chatsworth Schools, a rapidly expanding independent schools group backed by leading growth investor Synova, acquired Riverston...
You must be a Standard 1 Year member to access this content.
